Evolution of proximal kinase network in T cells
T细胞中近端激酶网络的进化
基本信息
- 批准号:10615817
- 负责人:
- 金额:$ 40.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-15 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:Adaptive Immune SystemAdaptor Signaling ProteinAffectAgonistAmino Acid SequenceAntigensB-LymphocytesBehaviorBindingBiochemicalBiologicalBiophysicsCD8B1 geneCell LineCell physiologyCellsChargeClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsComplexDiabetes MellitusDimerizationDiscriminationEngineeringEnvironmentEvolutionExhibitsFamilyFamily memberFutureGenesGenetic TranscriptionGlutamineGoalsHematopoieticInbred NOD MiceInsulin-Dependent Diabetes MellitusJurkat CellsKnock-outLCP2 geneLigandsLymphocyte-Specific p56LCK Tyrosine Protein KinaseMalignant NeoplasmsMediatingMembraneMethodsMoldsMolecular ConformationMonitorMusMutagenesisMutationOutcomePTPRC genePeptide/MHC ComplexPharmaceutical PreparationsPhosphatidylinositolsPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhylogenetic AnalysisPhysiologicalPropertyProtein DephosphorylationProtein DynamicsProtein Tyrosine KinaseProteinsRestRoleScaffolding ProteinSignal PathwaySignal TransductionSignal Transduction PathwaySignaling MoleculeSignaling ProteinSiteSortingStimulusStructureSubstrate SpecificitySyndromeT Cell Receptor Signaling PathwayT-Cell ActivationT-Cell DevelopmentT-Cell ReceptorT-LymphocyteTEC Protein Tyrosine KinaseTailTestingTreesUp-RegulationVariantZAP-70 Genedesignexome sequencingexperimental studyfitnessgrowth factor receptor-bound protein 2inhibitorinorganic phosphateinsightmembermembrane reconstitutionmutantnovelnuclear factors of activated T-cellspathogenpressureprogramsprotein purificationreceptorreconstitutionreconstructionresistance mutationresponsesingle moleculesrc Homology Region 2 Domainsrc-Family Kinases
项目摘要
PROJECT 1 - ABSTRACT
T cells are key components of the adaptive immune system, and have evolved to detect foreign antigens and
generate a response that protects the host from intracellular pathogens and malignancies. The activation of the
T cell receptor (TCR) results in the initiation of signal transduction pathways inside the T cell that generate the
appropriate antigen-triggered responses. The major goals of the Program Project are to understand how the
distinct features of the molecules and cellular circuitry in T cells allows for tonic signaling to self-pMHC, while
also establishing a stimulus threshold, which when overcome results in robust signaling to agonists. In Project
1 we focus on the tyrosine kinases activated by the TCR, to understand the distinct properties of these signaling
molecules, differentiating them from similar proteins operative in B cells. Our strategy is to use focused
biochemical, biophysical, and cell biological studies on kinase variants and particular functions, combined with
high-throughput methods for determining the fitness of variant proteins in supporting signal-transduction
functions in T cells, as contrasted to B cells.
The activation of intracellular signaling pathways by the TCR is mediated by three kinds of tyrosine kinases,
which are members of the Src, Syk, and Tec families. Although they share features of their signaling machinery
with other cells of the hematopoietic lineage, TCRs utilize a distinct set of members of these tyrosine kinase
families (i.e., Lck, ZAP-70 and Itk), interact with unique MHC binding co-receptors (i.e., CD4 and CD8 with Lck)
and phosphorylate unique scaffold proteins (e.g., LAT and SLP-76 for ZAP-70 and Itk) that couple to downstream
signaling pathways. These components evolved contemporaneously with the MHC genes, and have maintained
features in their sequences that mark them as distinct throughout the vertebrate evolutionary tree. A principal
goal of Project 1 is to understand the functional specializations that have optimized these kinases for their roles
in T cells.
Project 1 has three Specific Aims. In Aim 1, we will define the specialized properties of the Src-family kinase Lck
that are optimized for T cell function. These studies will include single-molecule tracking of Lck and variants to
monitor their activation and localization, as well as structural studies on the interaction between Lck and the
phosphatase CD45. In Aim 2 we will study the differentiation of ZAP-70 and Syk in T cells and B cells, by focusing
on aspects of the activation of these kinases that differ in B cells and T cells. In Aim 3 we study the specialized
differences in the activation mechanisms of Tec kinases, leading to different behavior on the membrane of Itk
and Btk, which are the Tec kinases operative in T cells and B cells, respectively. Together, these studies will
illuminate evolutionary pressures that have molded specialized responses from Lck, ZAP-70 and Itk, providing
a framework for the development of T cell-specific drugs.
项目1-摘要
T细胞是自适应免疫系统的关键组成部分,并且已进化为检测外国抗原和
产生一种保护宿主免受细胞内病原体和恶性肿瘤的反应。激活
T细胞受体(TCR)导致启动T细胞内部信号转导途径,从而产生
适当的抗原触发反应。该计划项目的主要目标是了解
T细胞中分子和细胞电路的不同特征允许对自PMHC进行强直信号传导,而
还建立一个刺激阈值,当克服时,它会导致对激动剂的强大信号。在项目中
1我们专注于TCR激活的酪氨酸激酶,以了解这些信号的不同特性
分子,将它们与B细胞中相似蛋白的手术区分开。我们的策略是使用专注
关于激酶变异和特定功能的生化,生物物理和细胞生物学研究,并结合
用于确定变异蛋白在支持信号转导的适应性的高通量方法
与B细胞形成鲜明对比的T细胞的功能。
TCR的细胞内信号通路的激活是由三种酪氨酸激酶介导的
是SRC,SYK和TEC家庭的成员。尽管他们共享信号机械的功能
与造血谱系的其他细胞一起,TCR使用了这些酪氨酸激酶的一组不同的成员
家族(即LCK,ZAP-70和ITK)与唯一的MHC结合共受体(即与LCK的CD4和CD8)相互作用
和磷酸化的独特脚手架蛋白(例如,ZAP-70和ITK的LAT和SLP-76)夫妇到下游
信号通路。这些成分与MHC基因同时发展,并保持
其序列中的特征在整个脊椎动物进化树中标记为不同。校长
项目1的目标是了解为其角色优化这些激酶的功能专业
在T细胞中。
项目1具有三个特定目标。在AIM 1中,我们将定义SRC家庭激酶LCK的专业特性
针对T细胞功能进行了优化。这些研究将包括LCK和变体的单分子跟踪
监控其激活和定位,以及有关LCK与LCK之间相互作用的结构研究
磷酸酶CD45。在AIM 2中,我们将通过聚焦在T细胞和B细胞中ZAP-70和SYK的分化
在这些激活的各个方面,这些激酶在B细胞和T细胞中不同。在AIM 3中,我们研究专业
TEC激酶激活机制的差异,导致ITK膜上不同的行为
BTK和BTK分别是TEC激酶在T细胞和B细胞中的作战。这些研究将在一起
照明从LCK,ZAP-70和ITK塑造了专门响应的进化压力,提供了
T细胞特异性药物开发的框架。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN KURIYAN其他文献
JOHN KURIYAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN KURIYAN', 18)}}的其他基金
Mechanism and Evolutionary Design of DNA Polymerase Clamp Loaders.
DNA 聚合酶夹钳装载机的机制和进化设计。
- 批准号:
10587243 - 财政年份:2023
- 资助金额:
$ 40.07万 - 项目类别:
Evolution of proximal kinase network in T cells
T细胞中近端激酶网络的进化
- 批准号:
10428138 - 财政年份:2011
- 资助金额:
$ 40.07万 - 项目类别:
STRUCTURAL STUDIES OF CALCIUM/CALMODULIN DEPENDENT KINASE II AND E COLI REPLICA
钙/钙调蛋白依赖性激酶 II 和大肠杆菌复制品的结构研究
- 批准号:
7598158 - 财政年份:2007
- 资助金额:
$ 40.07万 - 项目类别:
STRUCTURAL STUDIES OF CALCIUM/CALMODULIN DEPENDENT KINASE II AND E COLI REPLICA
钙/钙调蛋白依赖性激酶 II 和大肠杆菌复制品的结构研究
- 批准号:
7370608 - 财政年份:2006
- 资助金额:
$ 40.07万 - 项目类别:
CRYSTALLOGRAPHIC STUDIES OF DNA REPLICATION & CELLULAR SIGNALING: ONCOGENE
DNA 复制的晶体学研究
- 批准号:
6667808 - 财政年份:2002
- 资助金额:
$ 40.07万 - 项目类别:
CRYSTALLOGRAPHIC STUDIES OF DNA REPLICATION & CELLULAR SIGNALING: ONCOGENE
DNA 复制的晶体学研究
- 批准号:
6491131 - 财政年份:2001
- 资助金额:
$ 40.07万 - 项目类别:
STRUCTURAL STUDIES OF DNA POLYMERASE PROCESSIVITY CLAMP LOADERS
DNA 聚合酶连续夹具加载器的结构研究
- 批准号:
6483499 - 财政年份:2001
- 资助金额:
$ 40.07万 - 项目类别:
CRYSTALLOGRAPHIC STUDIES OF DNA REPLICATION & CELLULAR SIGNALING: ONCOGENE
DNA 复制的晶体学研究
- 批准号:
6339143 - 财政年份:2000
- 资助金额:
$ 40.07万 - 项目类别:
STRUCTURAL STUDIES OF DNA POLYMERASE PROCESSIVITY CLAMP LOADERS
DNA 聚合酶连续夹具加载器的结构研究
- 批准号:
6339323 - 财政年份:2000
- 资助金额:
$ 40.07万 - 项目类别:
相似海外基金
Skin microbiome regulation of the sebum-immune axis
皮肤微生物组对皮脂免疫轴的调节
- 批准号:
10732282 - 财政年份:2023
- 资助金额:
$ 40.07万 - 项目类别:
Regulation of Proinflammatory Cytokine Responses by a Caspase-8-N4BP1 Axis
Caspase-8-N4BP1 轴对促炎细胞因子反应的调节
- 批准号:
10704065 - 财政年份:2022
- 资助金额:
$ 40.07万 - 项目类别:
Therapeutic Targeting a Non-Hodgkin Lymphoma Driver Using AI
使用人工智能针对非霍奇金淋巴瘤驱动者进行治疗
- 批准号:
10585717 - 财政年份:2022
- 资助金额:
$ 40.07万 - 项目类别:
Regulation of T cell ligand discrimination by tuning the phosphorylation kinetics of Zap70 substrates
通过调节 Zap70 底物的磷酸化动力学来调节 T 细胞配体辨别
- 批准号:
10405414 - 财政年份:2021
- 资助金额:
$ 40.07万 - 项目类别:
Regulation of T cell ligand discrimination by tuning the phosphorylation kinetics of Zap70 substrates
通过调节 Zap70 底物的磷酸化动力学来调节 T 细胞配体辨别
- 批准号:
9720665 - 财政年份:2021
- 资助金额:
$ 40.07万 - 项目类别: